This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Tong, Y.K., Chiu, R.W.K., Chan, K.C.A., Leung, T.Y. & Lo, Y.M.D. Nat. Med. 18, 1327–1328 (2012).
Papageorgiou, E.A. et al. Nat. Med. 17, 510–513 (2011).
Tsaliki, E. et al. Prenat. Diagn. 10.1002/pd.3947 (26 July 2012).
Fan, H.C. et al. Proc. Natl. Acad. Sci. USA 105, 16266–16271 (2008).
Chiu, R.W. et al. Proc. Natl. Acad. Sci. USA 105, 20458–20463 (2008).
P.C.P. has filed a Patent Cooperation Treaty patent application (application no. PCT/IB2011/000217) for the MeDIP real-time quantitative PCR–based NIPD approach. The patent is now owned by NIPD Genetics Ltd. P.C.P. is a consultant with and holds equities in this company.
Rights and permissions
About this article
Cite this article
Patsalis, P. Reply to: Technical concerns about immunoprecipitation of methylated fetal DNA for noninvasive trisomy 21 diagnosis. Nat Med 18, 1328–1329 (2012). https://doi.org/10.1038/nm.2914